Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 Days and 14 Days
Condition: Helicobacter Pylori Infection Interventions: Drug: Amoxicillin; Drug: Clarithromycin; Drug: Tetracycline; Drug: Metronidazole; Drug: Bismuth Potassium Citrate; Drug: Colloidal Bismuth Pectin; Drug: Vonoprazan fumarate Sponsors: Shandong University; Maternity and Child Care Health Center of Dezhou; Heze Municipal 3rd people's hospital; PKUcare luzhong hospital; The First Affiliated Hospital with Nanjing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Amoxicillin | Biaxin | Clarithromycin | Clinical Trials | Helicobacter Pylori | Hospitals | Metronidazole | Research | Tetracycline